Blockbuster Trades Are Changing The Face Of Pharmaceuticals

April 23, 2014

Pharmaceutical companies are suddenly trading entire divisions the way sports teams swap players. Glaxo, Novartis and Ely Lily are all involved in a complicated deal announced Tuesday, and so far this year, five deals exceeding $2 billion have been announced. What’s driving the deal-making?